ReP USP - Resultado da busca

Artigo de periodico
Characterization of clinical predictors of naturally occurring NS3/NS4A protease polymorphism in genotype 1 hepatitis C virus mono and HIV co-infected patients (2017)
Neto, Gaspar Lisboa; Malta, Fernanda M.; Gomes-Gouvêa, Michele S.; Noble, Caroline F.; Romano, Camila M.; Pinho, João R. Rebello; Silva, Mariliza H.; Leite, Andrea G.B.; Piccoli, Leonora Z.; Carrilho, Flair J.; Mendes-Correa, Maria C.
Fonte: Journal of Medical Virology. Unidade: FM
Assuntos: POLIMORFISMO, INFECÇÕES OPORTUNISTAS, HEPATIE C, HIV, HEPATITE VIRAL HUMANA, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NETO, Gaspar Lisboa et al. Characterization of clinical predictors of naturally occurring NS3/NS4A protease polymorphism in genotype 1 hepatitis C virus mono and HIV co-infected patients. Journal of Medical Virology, v. 89, n. 12, 2017Tradução . . Disponível em: https://doi.org/10.1002/jmv.24900. Acesso em: 28 out. 2024.
APA
Neto, G. L., Malta, F. M., Gomes-Gouvêa, M. S., Noble, C. F., Romano, C. M., Pinho, J. R. R., et al. (2017). Characterization of clinical predictors of naturally occurring NS3/NS4A protease polymorphism in genotype 1 hepatitis C virus mono and HIV co-infected patients. Journal of Medical Virology, 89( 12). doi:10.1002/jmv.24900
NLM
Neto GL, Malta FM, Gomes-Gouvêa MS, Noble CF, Romano CM, Pinho JRR, Silva MH, Leite AGB, Piccoli LZ, Carrilho FJ, Mendes-Correa MC. Characterization of clinical predictors of naturally occurring NS3/NS4A protease polymorphism in genotype 1 hepatitis C virus mono and HIV co-infected patients [Internet]. Journal of Medical Virology. 2017 ; 89( 12):[citado 2024 out. 28 ] Available from: https://doi.org/10.1002/jmv.24900
Vancouver
Neto GL, Malta FM, Gomes-Gouvêa MS, Noble CF, Romano CM, Pinho JRR, Silva MH, Leite AGB, Piccoli LZ, Carrilho FJ, Mendes-Correa MC. Characterization of clinical predictors of naturally occurring NS3/NS4A protease polymorphism in genotype 1 hepatitis C virus mono and HIV co-infected patients [Internet]. Journal of Medical Virology. 2017 ; 89( 12):[citado 2024 out. 28 ] Available from: https://doi.org/10.1002/jmv.24900
Artigo de periodico
Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3 (2016)
Oliveira, Ketti G.; Malta, Fernanda M.; Nastri, Ana C. S. S.; Widman, Azzo; Faria, Paola L.; Santana, Rúbia A. F.; Alves, Venâncio A. F.; Carrilho, Flair J.; Pinho, João R. R.
Fonte: Medical Microbiology and Immunology. Unidade: FM
Assuntos: LIPÍDEOS, EXPRESSÃO GÊNICA, HEPATITE C, HEPATITE VIRAL HUMANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Ketti G. et al. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3. Medical Microbiology and Immunology, v. 205, n. 2, p. 111-117, 2016Tradução . . Disponível em: http://link.springer.com/article/10.1007/s00430-015-0431-0. Acesso em: 28 out. 2024.
APA
Oliveira, K. G., Malta, F. M., Nastri, A. C. S. S., Widman, A., Faria, P. L., Santana, R. A. F., et al. (2016). Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3. Medical Microbiology and Immunology, 205( 2), 111-117. doi:10.1007/s00430-015-0431-0
NLM
Oliveira KG, Malta FM, Nastri ACSS, Widman A, Faria PL, Santana RAF, Alves VAF, Carrilho FJ, Pinho JRR. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3 [Internet]. Medical Microbiology and Immunology. 2016 ; 205( 2): 111-117.[citado 2024 out. 28 ] Available from: http://link.springer.com/article/10.1007/s00430-015-0431-0
Vancouver
Oliveira KG, Malta FM, Nastri ACSS, Widman A, Faria PL, Santana RAF, Alves VAF, Carrilho FJ, Pinho JRR. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3 [Internet]. Medical Microbiology and Immunology. 2016 ; 205( 2): 111-117.[citado 2024 out. 28 ] Available from: http://link.springer.com/article/10.1007/s00430-015-0431-0
Artigo de periodico
Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection (2015)
Lisboa-Neto, Gaspar; Noble, Caroline F.; Pinho, João R. Rebello; Malta, Fernanda M.; Gomes-Gouvêa, Michele S.; Alvarado-Mora, Mónica V.; Silva, Mariliza H. da; Leite, Andrea G. B.; Piccoli, Leonora Z.; Rodrigues, Flaviane K.; Carrilho, Flair J.; Mendes-Correa, Maria C.
Fonte: Antiviral Therapy. Unidade: FM
Assuntos: MUTAÇÃO GENÉTICA, BRASILEIROS, PREVALÊNCIA, INFECÇÕES OPORTUNISTAS, HEPATITE C (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LISBOA-NETO, Gaspar et al. Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection. Antiviral Therapy, v. 20, p. 281-287, 2015Tradução . . Disponível em: http://www.intmedpress.com/serveFile.cfm?sUID=9531cb80-cdfa-4f36-9d0e-cbe538d2f7c9. Acesso em: 28 out. 2024.
APA
Lisboa-Neto, G., Noble, C. F., Pinho, J. R. R., Malta, F. M., Gomes-Gouvêa, M. S., Alvarado-Mora, M. V., et al. (2015). Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection. Antiviral Therapy, 20, 281-287. doi:10.3851/IMP2873
NLM
Lisboa-Neto G, Noble CF, Pinho JRR, Malta FM, Gomes-Gouvêa MS, Alvarado-Mora MV, Silva MH da, Leite AGB, Piccoli LZ, Rodrigues FK, Carrilho FJ, Mendes-Correa MC. Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection [Internet]. Antiviral Therapy. 2015 ; 20 281-287.[citado 2024 out. 28 ] Available from: http://www.intmedpress.com/serveFile.cfm?sUID=9531cb80-cdfa-4f36-9d0e-cbe538d2f7c9
Vancouver
Lisboa-Neto G, Noble CF, Pinho JRR, Malta FM, Gomes-Gouvêa MS, Alvarado-Mora MV, Silva MH da, Leite AGB, Piccoli LZ, Rodrigues FK, Carrilho FJ, Mendes-Correa MC. Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection [Internet]. Antiviral Therapy. 2015 ; 20 281-287.[citado 2024 out. 28 ] Available from: http://www.intmedpress.com/serveFile.cfm?sUID=9531cb80-cdfa-4f36-9d0e-cbe538d2f7c9
Trabalho de evento-resumo periodico
Genotype 1 versus 3 and cirrhosis status have stronger effect on hepatitis C viral kinetics during combination treatment than interferon dosage (2004)
Medeiro Filho, Jose E.; Neumann, Avidan U.; Mello, Isabel M.; Pinho, Joao R.; Malta, Fernanda M.; Silva, Luiz C, Da; Carrilho, Flair J.
Fonte: Hepatology. Nome do evento: Annual Meeting of The American Association for The Study of Liver Diseases. Unidade: FM
Assuntos: HEPATITE C (COMPLICAÇÕES), CIRROSE HEPÁTICA (ETIOLOGIA;TERAPIA), FÍGADO (PATOLOGIA), TRANSPLANTE D FÍGADO (ETIOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIRO FILHO, Jose E. et al. Genotype 1 versus 3 and cirrhosis status have stronger effect on hepatitis C viral kinetics during combination treatment than interferon dosage. Hepatology. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/hep.1840400505/pdf. Acesso em: 28 out. 2024. , 2004
APA
Medeiro Filho, J. E., Neumann, A. U., Mello, I. M., Pinho, J. R., Malta, F. M., Silva, L. C., & Carrilho, F. J. (2004). Genotype 1 versus 3 and cirrhosis status have stronger effect on hepatitis C viral kinetics during combination treatment than interferon dosage. Hepatology. Baltimore: Faculdade de Medicina, Universidade de São Paulo. doi:10.1002/hep.1840400505/pdf
NLM
Medeiro Filho JE, Neumann AU, Mello IM, Pinho JR, Malta FM, Silva LC, Carrilho FJ. Genotype 1 versus 3 and cirrhosis status have stronger effect on hepatitis C viral kinetics during combination treatment than interferon dosage [Internet]. Hepatology. 2004 ; 40( 4): 401A.[citado 2024 out. 28 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/hep.1840400505/pdf
Vancouver
Medeiro Filho JE, Neumann AU, Mello IM, Pinho JR, Malta FM, Silva LC, Carrilho FJ. Genotype 1 versus 3 and cirrhosis status have stronger effect on hepatitis C viral kinetics during combination treatment than interferon dosage [Internet]. Hepatology. 2004 ; 40( 4): 401A.[citado 2024 out. 28 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/hep.1840400505/pdf

Unidades USP

ReP

Filtros

Autores

Assuntos

Indexado em